Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.
about
The Philadelphia chromosome in leukemogenesisA critical role of CDKN3 in Bcr-Abl-mediated tumorigenesisCytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factorSTI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5Platelet Derived Growth Factor Alpha (PDGFRα) Induces the Activation of Cardiac Fibroblasts by Activating c-KitHOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cellsErythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP.The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer.Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL.BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.
P2860
Q26745531-F3ADEC48-0BF5-480C-9CCC-0FA89059751AQ34435100-56A8F0FD-C588-49A2-B20B-4042B3752A1AQ35143436-DFB08F74-5BA7-4295-A61B-FE37317CD262Q35946035-A26F5963-E740-4EEB-A0A8-310C83C1FE5DQ36977566-F6D59B72-A356-42BF-9B8B-0A9FE9B556FBQ37322648-614BF5DF-7595-421B-AA3F-99B4E0E025F1Q38638641-78741525-3350-49E6-914B-95FAC0A1A853Q38957651-C19000D6-55DB-43CF-A79C-AA4472189CB3Q39700468-92401A76-9CD2-4CF7-B9D2-4CFC1A8F08B4Q41978994-CD362893-DB5C-40DE-99C1-3BCB0ED871B3Q42278494-902AB81B-6A8F-4FB1-8A6C-FBE124A54E4CQ44460438-E2222FAD-A31F-498A-AA79-9A9CA0D559A2
P2860
Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@ast
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
type
label
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@ast
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
prefLabel
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@ast
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
P2093
P1476
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
P2093
Nimmanapalli R
Porosnicu M
Worthington E
P304
P407
P577
2001-02-01T00:00:00Z